FINWIRES · TerminalLIVE
FINWIRES

RBC表示,万事达卡的业绩指引对第二季度中东冲突结束的假设引发担忧。

By

-- 加拿大皇家银行资本市场(RBC Capital Markets)周五在一份电子邮件报告中指出,万事达卡(Mastercard,股票代码:MA)近期发布的业绩指引假设中东冲突将在第二季度得到解决,这引发了投资者对下半年潜在风险的担忧,如果冲突持续到第二季度之后。 RBC分析师表示,该公司第一季度调整后的盈利和营收均超出预期,并略微上调了2026年全年业绩指引。分析师指出,增值服务实现了多元化,收入持续增长,而且该公司在全球几乎所有信用卡都支持万事达卡代理支付功能。 然而,报告显示,由于中东冲突、业务组合调整以及斋月和复活节的特殊时间安排,4月份跨境交易量和旅行相关交易量分别下降了9%和2%。 分析师表示,万事达卡2026年全年业绩指引基于中东冲突将在第二季度结束的假设,这意味着第二季度将是业绩最疲软的季度,之后将开始复苏。他们指出,如果冲突持续,投资者将会讨论业绩指引将受到怎样的影响。 加拿大皇家银行维持对该公司股票的“跑赢大盘”评级,并将目标股价从656美元下调至629美元。

Price: $493.17, Change: $-9.75, Percent Change: -1.94%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU